Home Healthcare IT Medical Aesthetics Market Size, Top Share, Demand Report to 2030

Medical Aesthetics Market

Medical Aesthetics Market Size, Share & Trends Analysis Report By Type (Surgical, Non-surgical), By Product ( Energy-based,  Non-Energy-based), By Procedure (Surgical Procedures, Breast Augmentation, Rhinoplasty, Facelift And Body Lift, Other Surgical Procedures, Anti-Aging And Skin Rejuvenation, Tattoo And Scar Removal, Hair Removal, Lipolysis, Other Non-Surgical Procedures),  By Gender (Male, Female), By End-User (Hospitals and Clinics, Cosmetic Procedural Centers, Ambulatory Centers, Beauty centers and medical spas, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI18DR
Study Period 2018-2030 CAGR 9.5%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD 61.23 Billion
Forecast Year 2030 Forecast Year Market Size USD 138.64 Billion
Largest Market North America Fastest Growing Market Asia Pacific

Market Overview

The global medical aesthetics market size was valued at 61.23 USD billion in 2021. It is expected to reach around 138.64 USD billion by 2030, growing at a CAGR of 9.5% during the forecast period (2022–2030).

Wrinkles, crow's feet, undesirable skin hairs, tattoo removal, and other skin and cosmetic issues are treated using medical aesthetic procedures. Adults and the elderly have a high incidence of acceptance of medical aesthetic operations. Medical aesthetic procedure acceptance is driven by the availability of various treatments and growth in the number of skilled medical professionals worldwide offering non-surgical medical aesthetic procedures.

The two primary reasons driving the global medical aesthetics industry are an increase in the global geriatric population and people's per capita income. The market is expected to grow due to the increased use in medical aesthetic procedures and the number of cosmetic procedure facilities worldwide.

The high cost of operations and the risk and complications associated with medical aesthetic procedures are expected to impede the market growth. Another factor that could hinder market expansion is the scarcity of competent experts in emerging nations that can undertake medical aesthetic operations.

Market Dynamics

Market Driving Factors

Increase in Obesity among the Old Age People to Boost Market Progress

For public health organizations around the world, obesity is a severe issue that affects the elderly in the same manner that it affects the general population. Geriatric obesity has been noted in affluent countries. This market sector will develop because of the lesser chance of issues, faster recovery, and lower cost of these operations.

Breast augmentation and nose reshaping are the two main market drivers on the more invasive side. Both are expanding because of the availability of experienced surgeons and new, improved technologies.

Rising Demand for Aesthetic Treatments

Technological improvements and significant investments in research and development operations have introduced plastic surgeries, breast implants, botulinum toxin injection therapies, and other anti-aging treatments and products.

Strict rules and regulations have spurred producers to introduce safer and more effective anti-aging treatments, expanding the market's growth potential.

Even though department stores have historically distributed high-end anti-aging products, specialized retailers have increased their accessibility and availability. Online retailers, salons, spas, specialty retail stores, and direct response television, such as infomercials and home shopping channels, are now selling these products.

Market Restraining Factors

Clinical Risks and Consequences to Restrict Market Growth

Over the previous two decades, medical cosmetic operations have become increasingly fashionable. The market for aesthetic treatments has grown dramatically due to the number of doctors and surgeons providing safe and effective medical aesthetic treatments and the development of technologically upgraded items for the same. On the other hand, medical aesthetic procedures entail several potential side effects. Patients undergoing aesthetic treatment may face a variety of hazards and products after or during the process.

Market Key Opportunities

Medical aesthetics businesses have a lot of opportunities in developing nations like China, Brazil, Mexico, and India. Increased medical tourism, a growing adult population, rising disposable incomes, and increased awareness of aesthetic specialties create opportunities for medical devices in these countries. The presence of many surgeons in these developing countries also contributes to the medical aesthetics market growth.

Regional Analysis

The global medical aesthetics market is primarily classified into three regions, namely North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

North America leads the worldwide medical aesthetics market because of its substantial elderly population and abundance of medical aesthetic procedure centers. According to the Population Reference Bureau, North America's senior population was more than 54 million in 2021 and is anticipated to grow to 98 million by 2060. Rising per capita income and highly established cosmetic hospitals are two more aspects projected to promote market expansion. 

The Asia-Pacific medical aesthetics market is expected to increase during the forecast period. The market's expansion is attributed to the region's massive demographic base and the entry of essential corporations. The demand for medical aesthetics is rapidly growing in Thailand, Japan, and China due to the region's rising medical tourism.

The medical aesthetics market in Europe is expected to grow. The presence of many cosmetic surgery centers in the region and the availability of qualified professionals are two significant drivers driving market expansion.

The Middle East and Africa's medical aesthetics industries are expanding quickly due to the recent rise in tourism. The region's growing healthcare and cosmetics spending significantly contribute to market growth. Latin America has the smallest worldwide market share for medical aesthetics due to its inadequate healthcare infrastructure and cosmetic surgery facilities. Another aspect anticipated to limit market expansion is the region's low cosmetic surgery expenditure.

Report Scope

Report Metric Details
Segmentations
By Type
  1. Surgical
  2. Non-surgical
By Product
  1.  Energy-based
    1. Laser-based aesthetic device
    2. Light-based aesthetic device
    3. Ultrasound aesthetic device
    4. Radiofrequency (RF)-based aesthetic device
  2.  Non-Energy-based
    1. Botulinum toxin
    2. Dermal fillers
    3.  Implants
    4. Breast implants
    5. Facial implants
    6. Others
By Procedure
  1. Surgical Procedures
  2. Breast Augmentation
  3. Rhinoplasty
  4. Facelift And Body Lift
  5. Other Surgical Procedures
  6. Anti-Aging And Skin Rejuvenation
  7. Tattoo And Scar Removal
  8. Hair Removal
  9. Lipolysis
  10. Other Non-Surgical Procedures
 By Gender
  1. Male
    1. 18 years and below
    2. 19-34 years
    3. 35-50 years
    4. 51-64 years
    5. 65 years and above
  2. Female
    1. 18 years and below
    2. 19-34 years
    3. 35-50 years
    4. 51-64 years
    5. 65 years and above
By End-User
  1. Hospitals and Clinics
  2. Cosmetic Procedural Centers
  3. Ambulatory Centers
  4. Beauty centers and medical spas
  5. Others
Company Profiles Alma Lasers Ltd. (A Division of Sisram Medical Ltd.) Allergan Anika Therapeutics Inc. Cutera Inc. Cynosure (A Wholly Owned Subsidiary of Hologic Inc.) En. S.P.A. Fotona D.O.O. Galderma (A Subsidiary of Nestlé) Johnson & Johnson Merz Aesthetics Inc. (A Division of Merz Pharma GmbH & Co. KGaA) Medytox Inc. Sientra Inc. Sinclair Pharma PLC Solta Medical (A Division of Valeant Pharmaceuticals International Inc.) Syneron Medical Ltd. (A Part of Apax Partners)
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global medical aesthetics market is segmented by type and end-user. 

Based on type, the global market is classified into Surgical and Non-Surgical.

Surgical operations are divided into face, head, breast, and body and extremities. Facelift, Eyelid Surgery, and other methods are included under the front and head portion. Breast augmentation silicone, breast lift, and sub-segments exist within the breast segment. Abdominoplasty, Liposuction, and other procedures are included in the body & extremities chapter. Hyaluronic acid, and Botulinum toxin, are used in the injectable treatment. Facial rejuvenation is further segregated into the chemical peel, microdermabrasion, non-surgical skin tightening, and others.

The non-surgical segment will likely dominate the global medical aesthetics market share. The non-surgical procedures market is growing due to the procedures' non-invasive or minimally invasive nature, faster recovery times, and less pain during the process. An estimated 1.4 million surgical and non-surgical procedures were carried out in the previous year, with plastic surgeons performing an average 40% increase. The International Society of Aesthetic Plastic Surgery conducted over 12.6 million non-surgical medical aesthetic procedures, compared to 10.8 million surgical surgeries.

Based on end-user, the global market is classified into hospitals & clinics, cosmetic procedural centers, and ambulatory facilities.

As a result of the availability of cutting-edge techniques for surgical and non-surgical medical aesthetic operations, hospitals and clinics are anticipated to hold the most significant market share among end-users. With the rising demand for aesthetic functions worldwide and numerous new cosmetic centers opening, the cosmetic procedural centers market is predicted to rise rapidly.

Market Size By Type

Recent Developments

  • In March 2022, Dubai hosted the Dubai World Dermatology and Laser Conference and Exhibition - the region’s largest A&D event.
  • In March 2022, Dubai hosted the Dubai World Dermatology and Laser Conference and Exhibition - the region’s largest A&D event.
  • In January 2022, Sientra announced the acquisition of novel fat grafting technology from auragen aesthetics, LLC, which Accelerates Sientra’s vision to transform the art and scienceof plastic surgery beyond breast products to become a significant player in the medical aesthetics market.

Top Key Players

Medical Aesthetics Market Share of Key Players

Alma Lasers Ltd. (A Division of Sisram Medical Ltd.) Allergan Anika Therapeutics Inc. Cutera Inc. Cynosure (A Wholly Owned Subsidiary of Hologic Inc.) En. S.P.A. Fotona D.O.O. Galderma (A Subsidiary of Nestlé) Johnson & Johnson Merz Aesthetics Inc. (A Division of Merz Pharma GmbH & Co. KGaA) Medytox Inc. Sientra Inc. Sinclair Pharma PLC Solta Medical (A Division of Valeant Pharmaceuticals International Inc.) Syneron Medical Ltd. (A Part of Apax Partners)

Frequently Asked Questions (FAQs)

How big is the medical aesthetics market?
The global medical aesthetics market size was valued at 61.23 USD billion in 2021. It is expected to reach around 138.64 USD billion by 2030, growing at a CAGR of 9.5% from 2022 to 2030.
Non-surgical segment is the leading segment for the market during forecast period.
Rise in obesity among the old age people, increasing demand for aesthetic treatments are the major growth factors of the medical aesthetics market.
Asia Pacific region has the highest growth rate in the medical aesthetics market.
The key players in the global market include Alma Lasers Ltd, Allergan, Anika Therapeutics Inc., Cutera Inc., Cynosure, Galderma, Johnson & Johnson, Merz Aesthetics Inc., Medytox Inc., Sientra Inc., Sinclair Pharma PLC, Solta Medical.


We are featured on :